Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 24149102.
- Also identified by DOI 10.1038/ncomms3549 and PMC identifier 5053363.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In addition to HLA, recent genome-wide association studies (GWASs) of Hodgkin's lymphoma (HL) have identified susceptibility loci for HL at 2p16.1, 8q24.21 and 10p14. In this study, we perform a GWAS meta-analysis with published GWAS (totalling 1,465 cases and 6,417 controls of European background), and follow-up the most significant association signals in 2,024 cases and 1,853 controls. A combined analysis identifies new HL susceptibility loci mapping to 3p24.1 (rs3806624; P=1.14 × 10(-12), odds ratio (OR)=1.26) and 6q23.3 (rs7745098; P=3.42 × 10(-9), OR=1.21). rs3806624 localizes 5' to the EOMES (eomesodermin) gene within a p53 response element affecting p53 binding. rs7745098 maps intergenic to HBS1L and MYB, a region previously associated with haematopoiesis. These findings provide further insight into the genetic and biological basis of inherited susceptibility to HL.
Medical subject headings
- Chromosomes, Human, Pair 3
- Chromosomes, Human, Pair 6
- Genetic Predisposition to Disease
- Hodgkin Disease
- Polymorphism, Single Nucleotide